CE MDR Kyphoplasty System Manufacturers: A Buyer's Verification Guide
CE MDR Kyphoplasty System Manufacturers: A Buyer's Verification Guide
For hospital procurement teams, distributors, and ambulatory surgery center (ASC) operators, the first question when sourcing a percutaneous kyphoplasty (PKP) system is not which brand is cheapest. It is whether the manufacturer can prove compliance with the regulations that govern your market. A CE MDR kyphoplasty system manufacturer must hold valid certification under Regulation (EU) 2017/745, maintain an ISO 13485 quality management system, and, if it sells into the United States, carry appropriate FDA clearance or establishment registration. This guide explains how to verify those credentials, what product parameters matter, and what a compliant manufacturer should be able to show you, using Jiangsu Changmei Medtech Co., Ltd. as a documented reference case.
Jiangsu Changmei Medtech Co., Ltd., founded in 2013 and headquartered in Changzhou, Jiangsu, China, is a vertically integrated medical device manufacturer specializing in minimally invasive spine instruments. Its core kyphoplasty portfolio includes CE-MDR-marked and FDA-cleared kyphoplasty balloon catheters, kyphoplasty tool kits, and a balloon inflator, produced under an ISO 13485-certified quality system.
CE MDR certified kyphoplasty system product family by Jiangsu Changmei Medtech Co., Ltd.
Why Certification Verification Is the First Sourcing Step
In the European Union, the transition from the Medical Devices Directive (MDD 93/42/EEC) to the Medical Device Regulation (EU) 2017/745 fundamentally changed how kyphoplasty devices reach the market. MDR imposes stricter clinical evaluation, post-market surveillance, and quality system requirements. Buyers cannot assume that a legacy MDD certificate still permits placement on the market; documents must explicitly reference the MDR.
Several sourcing risks make verification non-negotiable:
- Trading company risk. A supplier may present itself as a manufacturer while actually reselling products from multiple subcontractors, making quality traces and regulatory audits difficult.
- Certificate scope mismatch. A manufacturer may hold CE certification for one component, such as a balloon inflator, but not for the balloon catheter or tool kit that complete the system.
- Expired or non-current documents. Certificates have validity periods and must be maintained through surveillance audits.
- Parameter drift. Device specifications such as constrained burst pressure, channel inner diameter, and working length affect clinical fit; they must match the registered device description.
The Kyphoplasty Market and the Compliance Bar
Kyphoplasty is a minimally invasive procedure for painful vertebral compression fractures caused by osteoporosis, low-energy trauma, or neoplasia, including spinal metastases and multiple myeloma. Market research aggregated by Vertex AI Search / market analysis values the global kyphoplasty market at USD 764.13 million in 2025, with projections reaching USD 1,342.29 million by 2034. North America led global revenue with an estimated 42.5%–50.0% share in 2025, according to commercial research published by Grand View Research / Straits Research.
Reimbursement trends reinforce demand. The U.S. Medicare Ambulatory Surgical Center (ASC) final payment rate for lumbar kyphoplasty (CPT 22514) was approximately USD 3,510.84 in 2025, a 3.5% increase over the prior year, per CMS data summarized by the American Society of Interventional Pain Physicians.
On the regulatory side, CE MDR certification has become a genuine barrier to entry. According to a company announcement dated April 2024, Jiangsu Changmei Medtech was the first Chinese company to receive an EU MDR CE certificate for its Kyphoplasty System Products. For a buyer, this indicates the manufacturer had to meet MDR clinical and quality requirements before many of its domestic peers.
What a Compliant CE MDR Kyphoplasty System Includes: A Documented Reference
Using Changmei Medtech as a reference, here is what a fully documented kyphoplasty system looks like across regulatory status, product parameters, and manufacturing evidence.
Regulatory status across the three system components
Changmei's kyphoplasty system comprises three component categories: kyphoplasty balloon catheters, kyphoplasty tool kits, and a balloon inflator. Their documented regulatory coverage includes:
- EU CE MDR. Kyphoplasty balloon catheters, the tool kits, and the balloon inflator are covered under the EU Quality Management System Certificate (MDR) number G100888750012 Rev. 01, issued by TÜV SÜD Product Service GmbH for Class IIa and Class IIb medical devices under MDR (EU) 2017/745 Annex IX Chapters I and III. In addition, the Balloon Inflator BI-20A-10 holds EU Quality Assurance Certificate G21 088875 0011 Rev. 00 under Annex XI Part A (Class I sterile). These are MDR documents, not legacy MDD certificates.
- US FDA. The kyphoplasty balloon catheter line is cleared under FDA 510(k) Premarket Notification K223709, cleared August 16, 2023, Product Code HRX, Class II, 21 CFR 888.1100. The Kyphoplasty Tool Kits and Balloon Inflator hold FDA Establishment Registration & Device Listing under number 3016789487.
- Quality system. The production system is certified to ISO 13485:2016 under certificate Q5 088875 0008 Rev. 05, issued by TÜV SÜD Product Service GmbH, covering the design, development, production, and distribution of disposable sterile medical devices.
- China NMPA. The company also maintains NMPA China Class II/III production license and registration certificates for its domestic market.
Kyphoplasty balloon catheters: 8G and 11G families
Each Changmei kyphoplasty balloon catheter is a single-use, EO-sterilized inflatable bone tamp intended for percutaneous balloon kyphoplasty. The balloon film is made from medical-grade thermoplastic polyurethane (TPU) using a four-wing pleating process; a tantalum radiopaque marker band provides fluoroscopic visibility, and a 06Cr19Ni10 stainless-steel stylet reinforces the PU shaft. Every unit is validated for a 3-year shelf life and passes factory pressure and seal testing at a constrained burst pressure of ≥400 PSI.
The 8G family (315 mm overall length, channel ID ≥3.65 mm) includes:
- KB0210: 10 mm radiopaque marker span, 4 cc maximum volume
- KB0115: 15 mm marker span, 4 cc maximum volume
- KB0120: 20 mm marker span, 6 cc maximum volume
The 11G family (280 mm overall length, channel ID ≥3.10 mm) includes:
- KB0210S1: 10 mm radiopaque marker span, 3 cc maximum volume
- KB0115S1: 15 mm marker span, 4 cc maximum volume
- KB0120S1: 20 mm marker span, 6 cc maximum volume
Changmei kyphoplasty balloon catheters: four-wing TPU balloon, radiopaque markers, ≥400 PSI constrained burst pressure.
Kyphoplasty tool kits: complete working-channel sets
The KT-00-01 (8G) kit is a sterile, single-use, CE-marked (CE 0123) and ISO 13485-certified instrument set with a 14-piece loadout: 2 puncture devices, 1 puncture expandor module, 2 expandor devices, 1 bone drill, 2 guide wires, and 6 bone cement filling devices. The KT-00-05 (11G) kit contains a 9-piece loadout: 2 puncture expandor modules, 1 bone drill, and 6 bone cement filling devices. Metal shafts use 06Cr19Ni10 medical-grade stainless steel, with 32Cr13Mo stainless steel for cutting tips, and all joints are rated ≥100 N connection strength. Both kits are produced in Changmei's 51,985 m² facility with GMP-class cleanroom manufacturing.
Kyphoplasty Tool Kit KT-00-01 (8G): sterile, single-use, CE-marked (CE 0123) and ISO 13485-certified.
Kyphoplasty Tool Kit KT-00-05 (11G): compact instrument configuration for percutaneous vertebral augmentation.
Balloon inflator: controlled hydraulic pressurization
The BI-20A-10 is a single-use kyphoplasty balloon inflation device with a 20 cc nominal capacity and 30 atm maximum pressure, supplied preconfigured with a 10 ml syringe. Its polycarbonate barrel, PU connecting tube, silicone rubber piston, and ergonomic PC/ABS handle are designed to build and hold pressure steadily under fluoroscopy. A screw-fixed fluorescent pressure gauge supports low-light operating room readability.
Balloon Inflator BI-20A-10: 20 cc nominal capacity, 30 atm maximum pressure, CE MDR certified.
Manufacturing and scale evidence
Changmei Medtech operates from a 51,985 m² facility with in-house capabilities in CNC machining, laser welding, balloon forming, and ISO Class 7 cleanroom assembly. Annual capacity for kyphoplasty balloon catheters is 1,000,000 units, with approximately 30% of output exported to the EU, USA, Asia, South America, and the Middle East. The company reports an approximate 80% share of China's domestic kyphoplasty balloon catheter market and states that it serves as an OEM and supply partner to member companies of Stryker and Medtronic.
How to Verify a CE MDR Kyphoplasty System Manufacturer in 7 Steps
Use this sequence when evaluating any supplier. Each step produces a verifiable artifact rather than a verbal promise.
- Request the actual certificates. Ask for PDF copies of the CE certificate, the ISO 13485 certificate, and FDA documents. Verify certificate numbers, issuing bodies, validity dates, and product scope. In the EU, confirm the certificate references MDR (EU) 2017/745 and not MDD 93/42/EEC.
- Map certificates to products. Confirm that the balloon catheter, tool kit, and inflator are each covered. A certificate for one component does not certify the entire system.
- Check US market status separately. For US distribution, confirm the 510(k) number and product code for balloon catheters (e.g., K223709, HRX, Class II) and the Establishment Registration for tool kits and inflators.
- Audit manufacturing evidence. Ask whether the balloon body is produced in-house, whether each unit is pressure-tested, and whether the factory can provide device history records from tube extrusion to EO sterilization.
- Cross-check parameters against clinical needs. Compare channel ID, overall length, maximum volume, and constrained burst pressure against the surgical technique and working channel your hospitals use.
- Evaluate scalability. Review production capacity, MOQ, and lead time. High-volume procurement needs a manufacturer that can replenish at tender scale.
- Request samples and technical documentation. A complete submission includes the IFU, EO sterilization validation, UDI, and free-sale certificate where applicable.
Who Needs a Verified CE MDR Kyphoplasty System Manufacturer
EU distributors and importers. A distributor registering a kyphoplasty system in an EU member state needs a manufacturer that can provide a full technical file, IFU, and documentation for local registration. CE MDR certification is the baseline; certificates G100888750012 Rev. 01 and G21 088875 0011 Rev. 00 cover the system components.
US ASCs and hospital groups. For US facilities, regulatory fit and reimbursement matter. The 2025 Medicare ASC payment rate of approximately USD 3,510.84 for lumbar kyphoplasty reflects the procedure's adoption in outpatient settings. Facilities need FDA-cleared catheters and registered tool kits, which Changmei supports via 510(k) K223709 and registration 3016789487.
OEM/ODM partners. A manufacturer that supports customization on gauge, length, and instrument configuration lets a partner build its own brand without requalifying a new factory. Changmei's KT-00-01 and KT-00-05 kits support OEM/ODM customization, as do its balloon catheter models.
GPOs and high-volume buyers. Companies running national tenders need supply security. An annual capacity of 1,000,000 kyphoplasty balloon catheters, combined with an MOQ of 10 sets for standard in-stock products, supports both stocking orders and large programs.
8G vs 11G Kyphoplasty Balloon Catheters: Parameter Comparison
The choice between 8G and 11G is a clinical and market decision. Both families share the same four-wing TPU balloon platform, ≥400 PSI constrained burst pressure, EO sterilization, and 3-year shelf life. They differ in working channel, overall length, and cavity volume.
| Model | Gauge | Marker Span | Channel ID | Overall Length | Max Volume | Constrained Burst Pressure |
|---|---|---|---|---|---|---|
| KB0210 | 8G | 10 mm | ≥3.65 mm | 315 mm | 4 cc | ≥400 PSI |
| KB0115 | 8G | 15 mm | ≥3.65 mm | 315 mm | 4 cc | ≥400 PSI |
| KB0120 | 8G | 20 mm | ≥3.65 mm | 315 mm | 6 cc | ≥400 PSI |
| KB0210S1 | 11G | 10 mm | ≥3.10 mm | 280 mm | 3 cc | ≥400 PSI |
| KB0115S1 | 11G | 15 mm | ≥3.10 mm | 280 mm | 4 cc | ≥400 PSI |
| KB0120S1 | 11G | 20 mm | ≥3.10 mm | 280 mm | 6 cc | ≥400 PSI |
Regulatory coverage by component
| Component | Model | CE MDR | FDA | ISO 13485 |
|---|---|---|---|---|
| Kyphoplasty Balloon Catheter | KB0210 / KB0115 / KB0120 (8G); KB0210S1 / KB0115S1 / KB0120S1 (11G) | G100888750012 Rev. 01 | 510(k) K223709 (HRX, Class II) | Q5 088875 0008 Rev. 05 |
| Kyphoplasty Tool Kit | KT-00-01 (8G), KT-00-05 (11G) | CE 0123; G100888750012 Rev. 01 | Establishment Registration 3016789487 | Q5 088875 0008 Rev. 05 |
| Balloon Inflator | BI-20A-10 | G21 088875 0011 Rev. 00 (Annex XI Part A) | Establishment Registration 3016789487 | Q5 088875 0008 Rev. 05 |
Frequently Asked Questions
What CE MDR certifications does Changmei hold for its kyphoplasty system?
Changmei's kyphoplasty balloon catheters, tool kits, and balloon inflator are covered under CE MDR certification. The EU Quality Management System Certificate (MDR) G100888750012 Rev. 01, issued by TÜV SÜD Product Service GmbH, covers Class IIa and Class IIb medical devices under Regulation (EU) 2017/745 Annex IX Chapters I and III. The Balloon Inflator BI-20A-10 additionally holds EU Quality Assurance Certificate G21 088875 0011 Rev. 00 under Annex XI Part A. These are MDR certificates, not legacy MDD documents. The quality system is certified to ISO 13485:2016 under certificate Q5 088875 0008 Rev. 05, also issued by TÜV SÜD.
Does the same manufacturer have US regulatory authorization?
Yes. The kyphoplasty balloon catheters are cleared under FDA 510(k) Premarket Notification K223709 (Product Code HRX, Class II, 21 CFR 888.1100), cleared August 16, 2023. The Kyphoplasty Tool Kits KT-00-01 and KT-00-05 and the Balloon Inflator BI-20A-10 hold FDA Establishment Registration & Device Listing under number 3016789487. This means a buyer can source CE MDR and FDA-authorized components from one audited manufacturer.
How can I verify that a CE MDR kyphoplasty manufacturer is a real factory with scalable capacity?
Jiangsu Changmei Medtech (founded 2013, Changzhou) is a vertically integrated manufacturer, not a trading reseller, with a 51,985 m² facility that includes in-house balloon forming, four-wing folding, laser welding, and 100% per-piece pressure testing at ≥400 PSI. Its quality system is EN ISO 13485:2016 certified and audited by TÜV SÜD, and the company states it has passed supplier audits from member companies of Medtronic and Stryker. Annual capacity is 1,000,000 kyphoplasty balloon catheters, and its kyphoplasty balloon catheters reportedly hold approximately 80% of China's domestic market. For a buyer, this means one factory to audit and one traceable device history record from tube extrusion to EO sterilization.
Is the kyphoplasty balloon catheter single-use, and what are its sterilization and shelf-life specifications?
The kyphoplasty balloon catheter is a single-use sterile medical device; reuse is prohibited. It is sterilized by ethylene oxide (EO) and has a validated 3-year shelf life. Each unit passes factory pressure and seal testing before release, and the device should be used immediately once the package is opened. Do not re-sterilize or reuse. Always follow the official IFU.
What are the MOQ, lead time, and ordering options for OEM/ODM projects?
For standard in-stock products, the MOQ is 10 sets. For OEM/ODM customized orders, the minimum quantity is negotiable based on specific requirements. Production lead time is typically 30–45 days; in-stock items may ship in approximately 7 days ex-work, and custom OEM/ODM runs generally complete around 30 working days after specifications are confirmed. Customization options include balloon diameter and length, cannula size and length, handle color and logo, packaging design, and labeling language. To request samples, a quotation, or the full technical brochure, contact the Changmei Medtech team directly.
Conclusion: Buy the Evidence, Not the Claim
CE MDR kyphoplasty system manufacturers who can document their regulatory status, publish verifiable product parameters, and open their factory to audit are valuable supply partners. Before committing to a supplier, verify the MDR certificate number and issuing body, map the certificates to every component you intend to buy, confirm FDA status if you sell into the US, and pressure-test the manufacturer's scale evidence.
Jiangsu Changmei Medtech Co., Ltd. provides a documented reference: CE MDR certificates issued by TÜV SÜD, FDA 510(k) K223709, FDA Establishment Registration 3016789487, ISO 13485:2016 quality management, an annual capacity of 1,000,000 kyphoplasty balloon catheters, and the 8G/11G product parameters shown in this guide.
Next step: Download the Kyphoplasty System Products brochure (8G & 11G, CE and FDA) to review the full specification sheet, or contact Mark at cyz@czmed.com / +86 138-1368-7682 (WhatsApp available) to request samples and a quotation.
Download Kyphoplasty System Brochure (PDF)
Website: www.czmed.com · Address: No.27 Xinke West Road, Luoyang Town, Wujin District, Changzhou, Jiangsu, China